Studies on the efficacy of a new 20% fat emulsion in pediatric parenteral nutrition.
A new 20% safflower oil emulsion was studied in a small series of pediatric patients. Eight infants and children were evaluated over a 2-week period. The 20% fat emulsion supplied a major portion of daily caloric requirements. No serious side effects or toxicity were noted. No major changes in blood chemistries were observed; however, a statistically significant increase in serum albumin was noted. In addition, 63% of the patients gained weight during the study. This investigation supports the contention that 20% Liposyn is a safe and effective component of a parenteral nutrition program for children.
D001835:Body Weight; D002648:Child; D002675:Child, Preschool; D005217:Fat Emulsions, Intravenous; D005260:Female; D006801:Humans; D007223:Infant; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D008297:Male; D010288:Parenteral Nutrition; D010289:Parenteral Nutrition, Total; D012450:Safflower Oil; D012709:Serum Albumin / Q000032:analysis
D005217:Fat Emulsions, Intravenous; D012709:Serum Albumin; D012450:Safflower Oil